Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study

OBJECTIVES: Hydroxychloroquine (HCQ) is widely used to treat rheumatic diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and Sjögren’s syndrome (SS). Cardiac arrhythmia has been concerned as important safety issue for HCQ. The aim of this study was to investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Chien-Hsien, Wei, James Cheng-Chung, Wang, Yu-Hsun, Tsai, Chin-Feng, Chan, Kuei-Chuan, Li, Li-Ching, Lo, Tse-Hsien, Su, Chun-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050346/
https://www.ncbi.nlm.nih.gov/pubmed/33868251
http://dx.doi.org/10.3389/fimmu.2021.631869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050346/
https://www.ncbi.nlm.nih.gov/pubmed/33868251
http://dx.doi.org/10.3389/fimmu.2021.631869

Ejemplares similares